Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
12.06
-0.02 (-0.17%)
Jun 20, 2025, 2:43 PM - Market open
Avanos Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Avanos Medical.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Avanos Medical.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 |
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +107.30% | Jun 21, 2023 |
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +157.05% | May 22, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +115.59% | May 4, 2023 |
Financial Forecast
Revenue This Year
685.44M
from 687.80M
Decreased by -0.34%
Revenue Next Year
708.90M
from 685.44M
Increased by 3.42%
EPS This Year
0.87
from -8.53
EPS Next Year
1.22
from 0.87
Increased by 40.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 705.6M | 729.8M | 753.9M |
| Avg | 685.4M | 708.9M | 732.4M |
| Low | 658.6M | 681.1M | 703.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.6% | 6.5% | 6.3% |
| Avg | -0.3% | 3.4% | 3.3% |
| Low | -4.3% | -0.6% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.89 | 1.31 | 1.50 |
| Avg | 0.87 | 1.22 | 1.46 |
| Low | 0.83 | 1.12 | 1.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 51.4% | 23.2% |
| Avg | - | 40.6% | 19.7% |
| Low | - | 28.9% | 15.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.